Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (271-280 of 370) with videos related to

Pageof 37
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|January 25, 2021
Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future researchKok Pin Ng, Hui Jin Chiew, Shahul Hameed, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2020
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scalesDavid F Tang-Wai, Eric E Smith, Marie-Andrée Bruneau, et al.
JAMA Network Open|August 29, 2025
The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer DiseaseEtienne Aumont, Joseph Therriault, Angela T H Kwan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2009
Creating a transatlantic research enterprise for preventing Alzheimer's diseaseZaven S Khachaturian, Jordi Camí, Sandrine Andrieu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individualsFiroza Z Lussier, Tharick A Pascoal, Mira Chamoun, et al.
The Lancet. Neurology|April 26, 2020
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohortsThomas K Karikari, Tharick A Pascoal, Nicholas J Ashton, et al.
Nature Aging|April 28, 2023
Biomarker modeling of Alzheimer's disease using PET-based Braak stagingJoseph Therriault, Tharick A Pascoal, Firoza Z Lussier, et al.
Nature Medicine|August 27, 2021
Microglial activation and tau propagate jointly across Braak stagesTharick A Pascoal, Andrea L Benedet, Nicholas J Ashton, et al.
Neurology|September 23, 2025
Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease StagesLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 11, 2021
Preclinical <i>in vivo</i> longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeuticMin Su Kang, Monica Shin, Julie Ottoy, et al.
Pageof 37

Showing results (271-280 of 370) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia (New York, N. Y.)|January 25, 2021
Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future researchKok Pin Ng, Hui Jin Chiew, Shahul Hameed, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2020
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scalesDavid F Tang-Wai, Eric E Smith, Marie-Andrée Bruneau, et al.
JAMA Network Open|August 29, 2025
The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer DiseaseEtienne Aumont, Joseph Therriault, Angela T H Kwan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 30, 2009
Creating a transatlantic research enterprise for preventing Alzheimer's diseaseZaven S Khachaturian, Jordi Camí, Sandrine Andrieu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individualsFiroza Z Lussier, Tharick A Pascoal, Mira Chamoun, et al.
The Lancet. Neurology|April 26, 2020
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohortsThomas K Karikari, Tharick A Pascoal, Nicholas J Ashton, et al.
Nature Aging|April 28, 2023
Biomarker modeling of Alzheimer's disease using PET-based Braak stagingJoseph Therriault, Tharick A Pascoal, Firoza Z Lussier, et al.
Nature Medicine|August 27, 2021
Microglial activation and tau propagate jointly across Braak stagesTharick A Pascoal, Andrea L Benedet, Nicholas J Ashton, et al.
Neurology|September 23, 2025
Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease StagesLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 11, 2021
Preclinical <i>in vivo</i> longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeuticMin Su Kang, Monica Shin, Julie Ottoy, et al.
Pageof 37